Tranexamic Acid API Pure Powder USP For Customer Compounding (Rx)

Tranexamic Acid API Pure Powder USP refers to the pure, active pharmaceutical ingredient (API) form of tranexamic acid that meets the quality and purity standards set by the United States Pharmacopeia (USP).

Ships in 2-4 business days.

What is Tranexamic Acid?

• Tranexamic acid is a synthetic derivative of the amino acid lysine.
• It is classified as an antifibrinolytic agent, meaning it helps prevent the breakdown of blood clots.
• Tranexamic acid inhibits the activation of plasminogen to plasmin, thereby reducing bleeding.

What Does API Pure Powder Mean?

• API (Active Pharmaceutical Ingredient): This is the primary, pharmacologically active compound used to make finished drugs.
• Pure Powder: The raw, unformulated, highly purified powder (almost 100% tranexamic acid), suitable for pharmaceutical manufacturing.
• This is not the finished medicine but the raw material used to prepare medications (tablets, capsules, injections).

What Does USP Mean?

• USP stands for United States Pharmacopeia.
• If a product is labeled "USP," it meets rigorous quality, purity, strength, and identity standards set by the USP.
• This means the powder's chemical composition, potency, and absence of impurities have been verified according to USP specifications.

Uses of Tranexamic Acid API Pure Powder USP

• Making prescription medications for:
  • Heavy menstrual bleeding (menorrhagia)
  • Surgical procedures to minimize blood loss
  • Hereditary angioedema and other rare bleeding disorders
  • Sometimes used topically or orally for melasma (skin hyperpigmentation) in dermatology

Tranexamic Acid USP for compounding is a medication used for the treatment or prevention of excessive bleeding or hemorrhage. It is commonly used during surgeries, dental procedures, and for heavy menstrual bleeding. Tranexamic Acid works by preventing the breakdown of blood clots, thereby reducing bleeding. It is also used as an antifibrinolytic agent to treat conditions such as hemophilia and von Willebrand disease. This medication is only available for compounding, which means it is not a commercially available product and must be prepared by a licensed pharmacist according to a specific formula prescribed by a healthcare provider. 

Tranexamic acid USP is an active pharmaceutical ingredient (API) used in prescription medications. It belongs to the class of drugs called antifibrinolytics, which work by preventing the breakdown of blood clots in the body.

Tranexamic acid USP is primarily used to prevent or treat excessive bleeding in patients with certain medical conditions, such as bleeding disorders, heavy menstrual bleeding, and postpartum hemorrhage. It is also used in dentistry and in surgeries to reduce bleeding.

Tranexamic acid USP is a synthetic form of the amino acid lysine and is available in various forms such as tablets, injections, and nasal sprays. It works by blocking the activity of plasmin, an enzyme responsible for breaking down blood clots. This helps to maintain normal blood clotting and control bleeding.

As an API, tranexamic acid USP is subject to strict quality control measures and must meet specific criteria for purity, strength, potency, and stability set by the USP. It is approved by the US Food and Drug Administration (FDA) and is considered safe and effective when used as directed by a healthcare professional.

CAS Number: 1197-18-8